argenx SE (ARGX): Price and Financial Metrics
argenx SE (ARGX)
Today's Latest Price: $244.46 USD
Updated Sep 17 6:55pm
Add ARGX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ARGX Stock Summary
- With a price/sales ratio of 134.82, Argenx Se has a higher such ratio than 97.74% of stocks in our set.
- Over the past twelve months, ARGX has reported earnings growth of 640.7%, putting it ahead of 97.55% of US stocks in our set.
- As for revenue growth, note that ARGX's revenue has grown 374.98% over the past 12 months; that beats the revenue growth of 98.28% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Argenx Se are DNLI, PRQR, FATE, AGIO, and NKTR.
- ARGX's SEC filings can be seen here. And to visit Argenx Se's official web site, go to www.argenx.com.
ARGX Stock Price Chart Technical Analysis Charts
ARGX Price/Volume Stats
| Current price | $244.46 | 52-week high | $272.74 |
| Prev. close | $239.32 | 52-week low | $103.75 |
| Day low | $239.40 | Volume | 233,000 |
| Day high | $245.03 | Avg. volume | 179,591 |
| 50-day MA | $238.85 | Dividend yield | N/A |
| 200-day MA | $182.71 | Market Cap | 11.49B |
argenx SE (ARGX) Company Bio
arGEN-X N.V., a clinical-stage biopharmaceutical company, focuses on creating and developing therapeutic antibodies for the treatment of cancer and autoimmune diseases. The company was founded in 2008 and is based in Breda, Netherlands.
Loading social stream, please wait...